Top categories
GSK to buy US cancer treatment firm Nuvalent for $10.6bn
British drugmaker’s new chief executive Luke Miels announces one of its biggest dealsBusiness live – latest updatesGS...
Nasdaq
↑
Chip Stocks
↓
GSK
↑
NUVALENT
↑
| Jun 9, 2026, 09:28 | The Guardian - Business | GSK to buy US cancer treatment firm Nuvalent for $10.6bn | Nasdaq concl | UP | ||
| Jun 9, 2026, 09:28 | The Guardian - Business | GSK to buy US cancer treatment firm Nuvalent for $10.6bn | Chip Stocks concl | DOWN | ||
| Jun 9, 2026, 09:28 | The Guardian - Business | GSK to buy US cancer treatment firm Nuvalent for $10.6bn | GSK Direct | UP | ||
| Jun 9, 2026, 09:28 | The Guardian - Business | GSK to buy US cancer treatment firm Nuvalent for $10.6bn | NUVALENT Direct | UP |